The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of nivolumab in patients with advanced non-small cell lung cancer (NSCLC) in Korea.
 
Keunchil Park
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Boehringer Ingelheim; Clovis Oncology; Hanmi; Kyowa Hakko Kirin; Lilly; Novartis; Ono Pharmaceutical; Roche
Speakers' Bureau - Boehringer Ingelheim
Research Funding - AstraZeneca
 
Eun Kyung Cho
No Relationships to Disclose
 
Jin Hyoung Kang
Honoraria - Boehringer Ingelheim; Bristol-Myers Squibb
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb
Research Funding - AstraZeneca; Lilly
 
Ji-Youn Han
No Relationships to Disclose
 
Jong Seok Lee
No Relationships to Disclose
 
Dong-Wan Kim
No Relationships to Disclose
 
Sang-We Kim
No Relationships to Disclose
 
Byoung Chul Cho
Honoraria - AstraZeneca; Boehringer Ingelheim; MSD; Novartis; Ono Pharmaceutical; Roche
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; MSD; Novartis; Ono Pharmaceutical; Roche
Speakers' Bureau - Novartis
Research Funding - AstraZeneca; Bayer; Novartis
 
Young Joo Min
No Relationships to Disclose
 
Ki Hyeong Lee
No Relationships to Disclose
 
Joo-Hang Kim
No Relationships to Disclose